-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Spyre Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2023.
- Spyre Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 50.9M shares, a 1085% increase year-over-year.
- Spyre Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 6.9M shares, a 105% increase from 2022.
- Spyre Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.37M shares, a 28.2% increase from 2021.
- Spyre Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 2.63M shares, a 95.1% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)